ClinicalTrials.Veeva

Menu
G

Genesis Research Services | Newcastle, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABP-671
OLX72021
Xanamem®
ABP-745
LY3009104
Baricitinib
Rimegepant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 9 total trials

A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

This study is designed to evaluate the safety, efficacy, tolerability, and pharmacokinetics (PK) of OLX72021 in medically healthy men with mild to mo...

Enrolling
Androgenetic Alopecia (AGA)
Drug: OLX72021
Drug: Placebo

This is a phase 2, international, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy and safety of ABP-671 in s...

Not yet enrolling
Chronic Kidney Disease
Drug: ABP-671 plus febuxostat Group 2
Drug: ABP-671 plus febuxostat Group 1

A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subj...

Enrolling
Acute Gouty Arthritis
Gout Flare
Drug: Placebo
Drug: Colchicine

Trial sponsors

A
A
Lilly logo
O
Pfizer logo
S
X
argenx logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems